Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000435787

Medchemexpress LLC Diethylcarbamazine | 90-89-1 | 99.8% | 199.29 | 500 MG
SDP

Catalog No. 5000435787
Encompass_Preferred

Diethylcarbamazine is an orally active microfilaricidal agent, effective in treating onchocerciasis and lymphatic filariasis. It exhibits anti-allergic effects by reducing eosinophil trafficking to lung tissue and modulates several biological pathways, including decreasing serum levels of leptin, TNF-α, IL-6, MCP-1, glucose, insulin, and triglycerides, thereby ameliorating insulin resistance.

  • Reduces eosinophil trafficking to lung tissue
  • Exerts anti-allergic effects
  • Decreases serum levels of leptin, TNF-α, IL-6, MCP-1, glucose, insulin, and triglycerides
  • Ameliorates insulin resistance
  • Enhances reactive oxygen intermediate expression by polymorphonuclear neutrophils
  • Increases lymphocyte proliferation
  • Inhibits actinomycetoma lesion development
  • Suitable for research in bronchial asthma, insulin resistance, and infection

Catalog No. 50-004-35787 Supplier Medchemexpress LLC Supplier No. HY12642A500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Diethylcarbamazine is an orally active microfilaricidal agent, effective in treating onchocerciasis and lymphatic filariasis. It exhibits anti-allergic effects by reducing eosinophil trafficking to lung tissue and modulates several biological pathways, including decreasing serum levels of leptin, TNF-α, IL-6, MCP-1, glucose, insulin, and triglycerides, thereby ameliorating insulin resistance.

  • Reduces eosinophil trafficking to lung tissue
  • Exerts anti-allergic effects
  • Decreases serum levels of leptin, TNF-α, IL-6, MCP-1, glucose, insulin, and triglycerides
  • Ameliorates insulin resistance
  • Enhances reactive oxygen intermediate expression by polymorphonuclear neutrophils
  • Increases lymphocyte proliferation
  • Inhibits actinomycetoma lesion development
  • Suitable for research in bronchial asthma, insulin resistance, and infection

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.